Hydroxychloroquine as Oral Antidiabetic Agent During Coronavirus Pandemic
<p>The coronavirus disease 2019 (COVID-19) is spreading rapidly. Hydroxychloroquine (HCQ), an old drug for treatment of malaria and autoimmune disease with acceptable safety, has shown promising but yet unproven effect against COVID-19 infection. HCQ is an approved agent by the Drug Controller...
-д хадгалсан:
Үндсэн зохиолч: | Anirban Majumder (Зохиогч) |
---|---|
Формат: | Ном |
Хэвлэсэн: |
Global Journal of Infectious Diseases and Clinical Research - Peertechz Publications,
2020-05-07.
|
Нөхцлүүд: | |
Онлайн хандалт: | Connect to this object online. |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Administration of chloroquine or hydroxychloroquine through feeding tubes: new challenges in times of coronavirus pandemic
-н: Mariana Martins Gonzaga do Nascimento, зэрэг
Хэвлэсэн: (2020) -
Ethical Considerations of Hydroxychloroquine During the COVID-19 Pandemic
-н: Amy Reese
Хэвлэсэн: (2021) -
Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
-н: Bao Sun, зэрэг
Хэвлэсэн: (2021) -
Hydroxychloroquine in obstetrics: potential implications of the prophylactic use of hydroxychloroquine for placental insufficiency during pregnancy
-н: Yoo-Min Kim, зэрэг
Хэвлэсэн: (2024) -
Hydroxychloroquine in obstetrics: potential implications of the prophylactic use of hydroxychloroquine for placental insufficiency during pregnancy
-н: Yoo-Min Kim, зэрэг
Хэвлэсэн: (2024)